Polymorphisms of eNOS gene are associated with diabetic nephropathy: A meta-analysis

Mutagenesis

Volumn 26, Issue 2, 2011, Pages 339-349

  He, Yanming ^a   Fan, Zhaohua ^a   Zhang, Jiyuan ^b   Zhang, Qiang ^a   Zheng, Min ^a   Li, Yunhao ^a   Zhang, Dan ^a   Gu, Shaohua ^b   Yang, Hongjie ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ALLELE; ARTICLE; ASIAN; CAUCASIAN; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ETHNICITY; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; HUMAN; META ANALYSIS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ASIAN CONTINENTAL ANCESTRY GROUP; DIABETIC NEPHROPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, GENETIC; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; PUBLICATION BIAS;

EID: 79952308197     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/geq100     Document Type: Article

References (69)

1. Association, A. D. (2002) Diabetic nephropathy. Diabetes Care, 25 (suppl. 1), S85-S89.
2. Borch-Johnsen, K., Norgaard, K., Hommel, E., Mathiesen, E. R., Jensen, J. S., Deckert, T. and Parving, H. H. (1992) Is diabetic nephropathy an inherited complication? Kidney Int., 41, 719-722.
3. Doria, A., Warram, J. H. and Krolewski, A. S. (1995) Genetic susceptibility to nephropathy in insulin-dependent diabetes: from epidemiology to molecular genetics. Diabetes Metab. Rev., 11, 287-314.
4. Quinn, M., Angelico, M. C., Warram, J. H. and Krolewski, A. S. (1996) Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia, 39, 940-945. (Pubitemid 26249113)
5. Hadjadj, S., Tarnow, L., Forsblom, C. et al. (2007) Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control, haplotype, and family-based study in three European populations. J. Am. Soc. Nephrol., 18, 1284-1291.
6. Lee, S. J., Choi, M. G., Kim, D. S. and Kim, T. W. (2006) Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients. Metabolism, 55, 1-7.
7. Moncada, S. and Higgs, E. A. (2006) The discovery of nitric oxide and its role in vascular biology. Br. J. Pharmacol., 147 (Suppl. 1), S193-S201.
8. Nagareddy, P. R., McNeill, J. H. and MacLeod, K. M. (2009) Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats. Eur. J. Pharmacol., 611, 53-59.
9. Nakayama, M., Yasue, H., Yoshimura, M. et al. (1999) T-786->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation, 99, 2864-2870. (Pubitemid 29258973)
10. Tesauro, M., Thompson, W. C., Rogliani, P., Qi, L., Chaudhary, P. P. and Moss, J. (2000) Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc. Natl Acad. Sci. USA, 97, 2832-2835.
11. Lamblin, N., Cuilleret, F. J., Helbecque, N., Dallongeville, J., Lablanche, J. M., Amouyel, P., Bauters, C. and Van Belle, E. (2005) A common variant of endothelial nitric oxide synthase (Glu298Asp) is associated with collateral development in patients with chronic coronary occlusions. BMC Cardiovasc. Disord., 5, 27.
12. Wang, X. L., Mahaney, M. C., Sim, A. S., Wang, J., Wang, J., Blangero, J., Almasy, L., Badenhop, R. B. and Wilcken, D. E. (1997) Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler. Thromb. Vasc. Biol., 17, 3147-3153.
13. Augeri, A. L., Tsongalis, G. J., Van Heest, J. L., Maresh, C. M., Thompson, P. D. and Pescatello, L. S. (2009) The endothelial nitric oxide synthase -786 T>C polymorphism and the exercise-induced blood pressure and nitric oxide responses among men with elevated blood pressure. Atherosclerosis, 204, e28-e34.
14. Wolff, B., Braun, C., Schluter, C., Grabe, H. J., Popowski, K., Volzke, H., Ludemann, J., John, U. and Cascorbi, I. (2005) Endothelial nitric oxide synthase Glu(298)->Asp polymorphism, carotid atherosclerosis and intima-media thickness in a general population sample. Clin. Sci. (Lond.), 109, 475-481.
15. Sinici, I., Atalar, E., Kepez, A., Hayran, M., Aksoyek, S., Tokgozoglu, L. and Ozmen, F. (2010) Intron 4 VNTR polymorphism of eNOS gene is protective for cardiac syndrome X. J. Investig. Med., 58, 23-27.
16. Neugebauer, S., Baba, T. and Watanabe, T. (2000) Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes, 49, 500-503. (Pubitemid 30131798)
17. Ahluwalia, T. S., Ahuja, M., Rai, T. S., Kohli, H. S., Sud, K., Bhansali, A. and Khullar, M. (2008) Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians. Mol. Cell Biochem., 314, 9-17.
18. Rippin, J. D., Patel, A., Belyaev, N. D., Gill, G. V., Barnett, A. H. and Bain, S. C. (2003) Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia, 46, 426-428.
19. Ezzidi, I., Mtiraoui, N., Mohamed, M. B., Mahjoub, T., Kacem, M. and Almawi, W. Y. (2008) Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy. J. Diabetes Complications, 22, 331-338.
20. Lau, J., Ioannidis, J. P. and Schmid, C. H. (1997) Quantitative synthesis in systematic reviews. Ann. Intern. Med., 127, 820-826.
21. Egger, M., Davey Smith, G., Schneider, M. and Minder, C. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-634. (Pubitemid 27387172)
22. Zanchi, A., Moczulski, D. K., Hanna, L. S., Wantman, M., Warram, J. H. and Krolewski, A. S. (2000) Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int., 57, 405-413. (Pubitemid 30430632)
23. Tiwari, A. K., Prasad, P. B. K. T., Kumar, K. M., Ammini, A. C., Gupta, A. and Gupta, R. (2009) Oxidative stress pathway genes and chronic renal insufficiency in Asian Indians with Type 2 diabetes. J. Diabetes Complications, 23, 102-111.
24. Mollsten, A., Lajer, M., Jorsal, A. and Tarnow, L. (2009) The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetes. Mol. Genet. Metab., 97, 80-84.
25. Mollsten, A., Wessman, M., Svensson, M., Forsblom, C., Parkkonen, M., Brismar, K., Groop, P. H. and Dahlquist, G. (2006) Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy. Ann. Med., 38, 522-528.
26. Shin Shin, Y., Baek, S. H., Chang, K. Y., Park, C. W., Yang, C. W., Jin, D. C., Kim, Y. S., Chang, Y. S. and Bang, B. K. (2004) Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy. Diabetes Res. Clin. Pract., 65, 257-265.
27. Frost, D., Chitu, J., Meyer, M., Beischer, W. and Pfohl, M. (2003) Endothelial nitric oxide synthase (ecNOS) 4 a/b gene polymorphism and carotid artery intima-media thickness in type-1 diabetic patients. Exp. Clin. Endocrinol. Diabetes, 111, 12-15.
28. Shimizu, T., Onuma, T., Kawamori, R., Makita, Y. and Tomino, Y. (2002) Endothelial nitric oxide synthase gene and the development of diabetic nephropathy. Diabetes Res. Clin. Pract., 58, 179-185.
29. Lin, S., Qu, H. and Qiu, M. (2002) Allele A in intron 4 of ecNOS gene will not increase the risk of diabetic nephropathy in type 2 diabetes of Chinese population. Nephron, 91, 768. (Pubitemid 34914089)
30. Degen, B., Schmidt, S. and Ritz, E. (2001) A polymorphism in the gene for the endothelial nitric oxide synthase and diabetic nephropathy. Nephrol. Dial. Transplant., 16, 185.
31. Fujita, H., Narita, T., Meguro, H., Ishii, T., Hanyu, O., Suzuki, K., Kamoi, K. and Ito, S. (2000) Lack of association between an ecNOS gene polymorphism and diabetic nephropathy in type 2 diabetic patients with proliferative diabetic retinopathy. Horm. Metab. Res., 32, 80-83.
32. Taniwaki, H., Ishimura, E., Matsumoto, N., Emoto, M., Inaba, M. and Nishizawa, Y. (2001) Relations between ACE gene and ecNOS gene polymorphisms and resistive index in type 2 diabetic patients with nephropathy. Diabetes Care, 24, 1653-1660. (Pubitemid 33716465)
33. Fu, Z. J., Li, C. G. and Wang, Z. C. (2007) Coexistence of aldose reduction gene and endothelial nitric oxide synthase polymorphisms associates with diabetic nephropathy. J. CRTER, 11, 6893-6896.
34. Ma, J. R., Yu, D. M. and Liu, D. M. (2007) The relationship between the G894T mutation of the endothelial-cosistitutive nitric oxide synthase(ec-NOS) and type 2 diabetic microangiopathies. Chin. J. Diabetes, 15, 471-473.
35. Lv, S. Y., Xing, Q. Q. and Li, C. G. (2003) Association between 894G-T polymorphism at exon 7 of endothelial nitric oxide synthase gene and diabetic nephropathy with or without hypertention. Chin. J. Mult. Organ Dis. Elderly, 2, 275-311.
36. Zhang, M., Liu, H., Yang, H. Y., Wang, Y. M., Song, D. P. and Li, H. (2005) Relationship of endothelial nitric oxide synthase (eNOS) 4a/bgene polymorphism with diabetic nephropathyin T2DM. Chin. J. Diabetes, 13, 284-285.
37. Sun, H. Y., Yang, M. G., Liu, S. Q., Wang, C. J., Zhang, Q. and Chen, M. W. (2004) Study on the correlation of the polymorphisms of endothelial nitric oxide synthase gene with type 2 diabetes mellitus and diabetic nephropathy. Chin. J. Prev. Contr. Chron. Non-commun. Dis., 12, 101-103.
38. Luo, H. and Ning, Y. Y. (2003) Association of polymorphism of endothelial nitric oxide synthase gene with diabetic nephropathy. Chin. J. Diabetes, 11, 317-320.
39. Li, C., Dong, Y. and Lu, W. (2001) [The association between polymorphism of endothelial nitric oxide synthase gene and diabetic nephropathy]. Zhonghua Nei Ke Za Zhi, 40, 729-732.
40. Dong, Y. H., Qu, S. P., Lu, W. S., Ding, M., Dong, C. and Jiang, H. W. (2005) Gene polymorphism in chromosome 7q35 and susceptibility to diabetic nephropathy. Chin. J. Endocrinol. Metab., 21, 47-50.
41. Xing, Q., Su, B. L., Li, C. C., Du, J. L., Bai, R. and Zhang, J. N. (2004) Association between edothelial nitric oxide synthase gene polymeophism and type 2 diabetic nephropathy. Chin. J. Endocrinol. Metab., 20, 435-437.
42. Huang, H. B., ling, L. X. and Chen, M. Q. (2003) Relationship between eNOS gene polymophism and diabetic nephropathy. Chin. J. Nephro., 19, 181-182.
43. Sohni, Y. R., Burke, J. P., Dyck, P. J. and O'Kane, D. J. (2003) Microfluidic chip-based method for genotyping microsatellites, VNTRs and insertion/deletion polymorphisms. Clin. Biochem., 36, 35-40.
44. Thaha, M., Pranawa, Yogiantoro, M., Sutjipto, Sunarjo, Tanimoto, M., Gohda, T. and Tomino, Y. (2008) Association of endothelial nitric oxide synthase Glu298Asp polymorphism with end-stage renal disease. Clin. Nephrol., 70, 144-154.
45. Bellini, M. H., Figueira, M. N., Piccoli, M. F. et al. (2007) Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end-stage renal disease. Nephrology (Carlton), 12, 289-293. (Pubitemid 46718205)
46. Kahn, S. E. (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia, 46, 3-19.
47. Noiri, E., Satoh, H., Taguchi, J. et al. (2002) Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension, 40, 535-540.
48. Asakimori, Y., Yorioka, N., Taniguchi, Y., Ito, T., Ogata, S., Kyuden, Y. and Kohno, N. (2002) T(-786)->C polymorphism of the endothelial nitric oxide synthase gene influences the progression of renal disease. Nephron, 91, 747-751. (Pubitemid 34914082)
49. Asanuma, K., Yokoyama, K., Tsukada, T., Takemoto, F., Hara, S., Yamada, A. and Tomino, Y. (2001) An intron 4 gene polymorphism in endothelial cell nitric oxide synthase might modulate lipid metabolism in nondiabetic patients on hemodialysis. Nephron, 88, 39-43. (Pubitemid 32429701)
50. Wang, Y., Kikuchi, S., Suzuki, H., Nagase, S. and Koyama, A. (1999) Endothelial nitric oxide synthase gene polymorphism in intron 4 affects the progression of renal failure in non-diabetic renal diseases. Nephrol. Dial. Transplant., 14, 2898-2902.
51. Dong, J. J., Zhao, J. J., Li, G. A., Lin, M. Q., Chen, S. W. and Liao, L. (2007) Distribution of polymorphism in endothelial nitric oxide synthase gene in mainland Chinese and Singapore Chinese and its association with diabetic nephropathy. Natl Med. J. China, 87, 3415-3417.
52. Liao, L., Zhao, J. J., Lim, M. C., Chan, S. W. and Lee, K. O. (2004) The association of a polymorphism in endothelial nitric oxide synthase gene with diabetic nephropathy. Chin. J. Lab. Med., 27, 303-306.
53. Masuda, Y., Shimizu, A., Mori, T. et al. (2001) Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am. J. Pathol., 159, 599-608.
54. Ziche, M., Morbidelli, L., Choudhuri, R., Zhang, H. T., Donnini, S., Granger, H. J. and Bicknell, R. (1997) Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J. Clin. Invest., 99, 2625-2634.
55. Brodsky, S. V., Gao, S., Li, H. and Goligorsky, M. S. (2002) Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells. Am. J. Physiol. Heart Circ. Physiol., 283, H2130-H2139.
56. Du, X. L., Edelstein, D., Dimmeler, S., Ju, Q., Sui, C. and Brownlee, M. (2001) Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J. Clin. Invest., 108, 1341-1348.
57. Nakagawa, T., Sato, W., Glushakova, O. et al. (2007) Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J. Am. Soc. Nephrol., 18, 539-550.
58. Joshi, M. S., Mineo, C., Shaul, P. W. and Bauer, J. A. (2007) Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear. FASEB J., 21, 2655-2663.
59. Laumonnier, Y., Nadaud, S., Agrapart, M. and Soubrier, F. (2000) Characterization of an upstream enhancer region in the promoter of the human endothelial nitric-oxide synthase gene. J. Biol. Chem., 275, 40732-40741.
60. Nakayama, M., Yasue, H., Yoshimura, M. et al. (2000) T(-786)->C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis. Am. J. Cardiol., 86, 628-634.
61. Hossain, P., Kawar, B. and El Nahas, M. (2007) Obesity and diabetes in the developing world - a growing challenge. N. Engl. J. Med., 356, 213-215.
62. Lee, G. (2003) End-stage renal disease in the Asian-Pacific region. Semin. Nephrol., 23, 107-114.
63. (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet, 352, 837-853.
64. Brownlee, M. (2001) Biochemistry and molecular cell biology of diabetic complications. Nature, 414, 813-820.
65. Kuboki, K., Jiang, Z. Y., Takahara, N. et al. (2000) Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation, 101, 676-681. (Pubitemid 30094740)
66. Goligorsky, M. S., Chen, J. and Brodsky, S. (2001) Workshop: endothelial cell dysfunction leading to diabetic nephropathy: focus on nitric oxide. Hypertension, 37, 744-748. (Pubitemid 32199060)
67. Tan, K. C., Chow, W. S., Tam, S. C., Ai, V. H., Lam, C. H. and Lam, K. S. (2002) Atorvastatin lowers C-reactive protein and improves endothelium- dependent vasodilation in type 2 diabetes mellitus. J. Clin. Endocrinol. Metab., 87, 563-568.
68. Tuttle, K. R. and Anderson, P. W. (2003) A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition. Am. J. Kidney Dis., 42, 456-465.
69. Ishii, H., Jirousek, M. R., Koya, D. et al. (1996) Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science, 272, 728-731. (Pubitemid 26000279)